Author: openjargon

  • Netflix vs. Paramount: Why each media giant says it has the best Warner Bros. Discovery offer

    David Ellison of Paramount Skydance and Ted Sarandos of Netflix
    David Ellison of Paramount Skydance and Ted Sarandos of Netflix are mounting rival bids for Warner Bros. Discovery.

    • Paramount Skydance made a hostile bid for Warner Bros. Discovery after Netflix won a bidding war.
    • Both companies cited regulatory approval, Hollywood employment, and consumers in their pitches.
    • Here's how each media giant is making its case to stakeholders.

    Hollywood's latest high-drama battle of the titans: Paramount versus Netflix.

    David Ellison's Paramount made a hostile bid for Warner Bros. Discovery after WBD rebuffed its multiple offers and accepted Netflix's offer to buy its studio and streaming business.

    This means Ellison, who is backed by his billionaire father, Larry Ellison of Oracle, is making his case directly to shareholders on why he'd be the best owner for WBD.

    "We have faster regulatory certainty to close," Ellison said. He called the deal "pro-consumer, pro-creative talent," and "pro-competition."

    Netflix didn't respond to the hostile bid but has said that by combining its streaming hits with WBD's classic library and prestige HBO fare, it can supercharge its offering.

    "Together, we can give audiences around the world even more value and choice, and get one step closer to being the most loved and the most valued entertainment company," Netflix co-CEO Ted Sarandos said in announcing the deal Friday.

    Here's how the companies made their cases to various stakeholders, which include investors, employees, Hollywood talent, and regulators.

    Paramount Skydance says it is offering a higher price and more certainty

    Financials: Paramount offered $30 per WBD share for all of WBD, compared to Netflix's offer of $27.75 per WBD share for its streaming and studios business, excluding its TV networks, such as CNN and TNT. While Netflix's offer was a mix of cash and stock, Ellison emphasized that Paramount's offer is all cash, and $17.6 billion more than the Netflix deal, an $82.7 billion offer that includes $72 billion in equity.

    Approval: Ellison repeatedly argued that he's more likely to win regulatory approval than Netflix is. He said he anticipated approval coming in as little as 12 months. President Donald Trump said he'll be "involved" in evaluating the deal. Larry Ellison is a longtime ally of Trump, and the firm of Trump's son-in-law, Jared Kushner, is part of the Paramount offer.

    Hollywood and consumers: Ellison argued that the Paramount deal would be good for jobs and consumers. He said Paramount is committed to growing the film and TV output of both businesses, including a theatrical slate of 30-plus releases a year. It's a pointed contrast with Netflix, whose preference for getting movies onto its streaming service quickly has created friction with the film industry. (Netflix has said it would continue to release Warner Bros. movies in theaters.) Ellison said adding WBD would make Paramount a robust competitor to Netflix, while Netflix buying WBD would extend its dominance in streaming and give it more power to raise prices to consumers.

    Netflix says its offer would be better for consumers and creators

    Financials: Netflix said the deal would give it a number of financial benefits. While Netflix is the top subscription streaming service, it has a ways to go in creating culture-defining IP. A big part of Netflix's pitch is that it'll be able to build on WBD's famous franchises like DC Comics and Harry Potter, fueling a flywheel that'll expand its business. WBD would have to pay a $2.8 billion breakup fee if it accepts a different offer, which Netflix said limited its risk. On the other hand, Netflix would have to pay a $5.8 billion breakup fee if the deal were blocked by regulators.

    Approval: Wall Street analysts have generally characterized Netflix as having a tougher approval path. However, the company has been making the pitch to Trump and his administration. Trump said Sunday that Netflix co-CEO Ted Sarandos visited him last week. Trump said Sarandos was a "great person" who has done "one of the greatest jobs in the history of movies." However, Trump added that Netflix has "a very big market share," which "could be a problem." Netflix expressed confidence in the approval process, saying it expects the deal to close in 12 to 18 months, after WBD completes its spinoff of linear channels into a new company, Discovery Global.

    Hollywood and consumers: Netflix said the deal would provide better choice and value for consumers by bringing together the Warner Bros. film and TV show libraries with its own offerings, and help the WBD's creators reach a bigger audience. Netflix said many of its subscribers don't subscribe to HBO Max.

    With Hollywood employment stagnating, Netflix also argued that the addition of Warner Bros. would let it expand its production and increase jobs over the long term. It expects to achieve $2 billion to $3 billion in cost savings from the deal, primarily coming from eliminating overlapping support staff.

    Read the original article on Business Insider
  • LinkedIn cofounder Reid Hoffman says he learned a lesson from a visit to Epstein’s island: ‘Note to self, Google before going’

    Reid Hoffman
    Hoffman said he was told Epstein would be more likely to donate if he visited the island.

    • Reid Hoffman said he once spent a night on Epstein's island in connection with MIT fundraising efforts.
    • The LinkedIn cofounder told the Newcomer podcast that he had been told a visit would make Epstein more likely to donate.
    • Hoffman has previously apologized publicly for his interactions with Epstein.

    LinkedIn cofounder Reid Hoffman said he wishes he'd known a little more before agreeing to spend a night on Jeffrey Epstein's island.

    On the Dec. 1 episode of Eric Newcomer's podcast, Hoffman said that he visited the island as part of his fundraising work for the MIT Foundation and was told the visit would make Epstein more likely to donate to MIT.

    "Note to self: Google before going," Hoffman said on the podcast. He said he stayed on the island for one night, and that there was a pool, a "bunch of guest rooms," and a courtyard.

    Epstein island
    Hoffman said he went to the island once.

    Hoffman has maintained that he only interacted with Epstein, whose 2019 death while awaiting trial on sex-trafficking charges was ruled a suicide, through his work fundraising for the MIT Media Lab. On the "Newcomer" podcast, he called Epstein a "masterful networker," and recalled a 2015 dinner he hosted for an MIT researcher in Palo Alto, California.

    Hoffman said that Joi Ito, former director of the MIT Media Lab, asked him if Epstein could attend the dinner, which was also attended by Meta CEO Mark Zuckerberg and Tesla CEO Elon Musk. Similar to his visit to the island, Hoffman said he was later told that the financier had said he was more likely to donate if he attended the dinner.

    "He's kind of going through the network, trying to meet people and so forth," Hoffman said on the podcast. Hoffman also reiterated previous apologies for his involvement with Epstein.

    In 2019, a spokesperson for Zuckerberg confirmed the dinner to Business Insider and said it was the only time the Facebook cofounder met Epstein. A spokesperson for Musk also confirmed the Tesla CEO's attendance.

    In a 2019 email to Axios, Hoffman acknowledged multiple interactions with Epstein, which he said were strictly for fundraising purposes, and said he had been told MIT had vetted and approved the convicted sex offender's participation. He said in the email he was "deeply regretful" of the involvement.

    "I went and kind of made a, you know, very public apology because it was like, okay I realized this and I'd already at that point had ramped down connection with him, right, to like no meetings and all the rest of the stuff, under any context," Hoffman said on the podcast. "And I think he still would drop me an email every so often and say, 'Hey, can we get on the phone?' I say, 'Oh, maybe sometime,' which is, you know, code for never, right?"

    Hoffman said that justice for the late pedophile's victims is important, and urged the government to release, unredacted, "every single piece of intel that they have about Epstein."

    In November, President Donald Trump signed a bill that will release the Department of Justice's files on Epstein after months of pressure from Congress, including some fellow Republicans. The department has until Saturday, December 19, to comply with the order.

    Trump has also ordered the DOJ to investigate Hoffman, along with other individuals he views as political enemies, including former President Bill Clinton and former Treasury Secretary Larry Summers, over their ties to Epstein.

    Hoffman, a billionaire and major Democratic donor, has previously said that he had to hire security after Musk fueled conspiracy theories about his relationship with Epstein.

    Read the original article on Business Insider
  • Is Sigma Healthcare share a healthy buy, after hitting new lows?

    A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.

    The Sigma Healthcare Ltd (ASX: SIG) share is slowly slipping toward this year’s record low of $2.74. Monday it lost another 2% to close at $2.79.

    In 2025, the $33 billion dollar pharmacy group has lost 5.2% in value and in the past 6 months 10%. To put this in context, the S&P/ASX 200 Index (ASX: XJO) gained 5.4% this year.

    The tumble has left some investors are asking: is Sigma Healthcare share a buy-the-dip opportunity?

    Short-term headwinds

    The slide in the Sigma Healthcare share reflects growing caution around short-term headwinds. Beneath the turbulence, Sigma remains a major player in Australian health care, and there are reasons to believe its long-term outlook still holds promise.

    Sigma is a leading Australian pharmaceutical wholesaler and retail group, supplying medicines and healthcare goods to community pharmacies and operating brands such as Amcal, Discount Drug Stores, and Chemist Warehouse.

    Rocketing integration expenses

    So why has the price of the ASX healthcare share dropped? A major factor has been a steep increase in transaction and integration costs tied to its recent merger with Chemist Warehouse and restructuring efforts. The extra costs weighed on profitability, and the sharp focus on merger expenses put pressure on investor confidence.

    Moreover, past operational missteps have left a mark. A poorly executed enterprise resource planning (ERP) rollout a couple of years ago disrupted supply chains. This triggered customer losses and prompted many pharmacies to re-contract with other wholesalers.

    That dented market share and eroded trust in execution, forcing Sigma to restructure and simplify its business.

    Powerful Chemist Warehouse synergies

    Still, the Sigma Healthcare share also has solid strengths. The company’s recent merger with Chemist Warehouse has dramatically expanded Sigma’s scale, bringing together wholesale, distribution and retail under one roof. This model could deliver powerful synergies.

    Additionally, the demographics underpinning demand remain favourable. An ageing population combined with rising demand for over the counter and health-related products gives the company a foundation for long-term stability.

    On the flip side, risks remain. The steep integration and merger costs have dented earnings in the near term, making Sigma Healthcare shares vulnerable until those investments begin to pay off.

    Is Sigma Healthcare share a buy, hold or sell?

    Looking ahead, analysts offer a cautious but mixed picture. Some see value now that the shares are near recent lows, noting that the merger gives Sigma a shot at becoming Australia’s leading pharmacy-wholesale-retail group.

    Broker’s recommendations span from strong buy to strong sell with an average target price over 12 months at $3.21, representing 15% upside.

    UBS currently has a price target of $3.40, implying a potential gain of 18% over the next year. The broker is also expecting the company to pay an annual dividend of 4 cents per share in the 2026 financial year.

    Ord Minnett has a buy recommendation on Sigma Healthcare.

    The broker recently noted:

    SIG has started strongly in fiscal year 2026, with Chemist Warehouse posting double-digit network sales growth and an upgraded synergies target. Furthermore, we continue to expect upside via the international rollout and private label strategies.

    The post Is Sigma Healthcare share a healthy buy, after hitting new lows? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sigma Healthcare right now?

    Before you buy Sigma Healthcare shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sigma Healthcare wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 5 things to watch on the ASX 200 on Tuesday

    A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought

    On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a small decline. The benchmark index fell 0.1% to 8,624.4 points.

    Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

    ASX 200 expected to fall again

    The Australian share market looks set to fall on Tuesday following a poor start to the week on Wall Street. According to the latest SPI futures, the ASX 200 is poised to open the day 30 points or 0.35% lower. In late trade in the United States, the Dow Jones is down 0.55%, the S&P 500 is 0.5% lower, and the Nasdaq has fallen 0.35%.

    Oil prices fall

    It could be a poor session for ASX 200 energy shares such as Karoon Energy Ltd (ASX: KAR) and Santos Ltd (ASX: STO) after oil prices fell overnight. According to Bloomberg, the WTI crude oil price is down 2.1% to US$58.81 a barrel and the Brent crude oil price is down 2.1% to US$62.44 a barrel. This was driven by optimism over the Russia-Ukraine peace deal.

    Reserve Bank meeting

    All eyes will be on the Reserve Bank of Australia today when it makes a decision on Australian interest rates. According to the ASX 30 Day Interbank Cash Rate Futures December 2025 contract, the market is pricing in only a 3% chance of a rate cut at today’s meeting. The big question, though, is whether the central bank will give hints about whether the cuts are over and hikes are coming in 2026.

    Hold Cobram shares

    Cobram Estate Olives Ltd (ASX: CBO) shares are a fairly valued according to analysts at Bell Potter. This morning, the broker has reaffirmed its hold rating and $2.90 price target on the olive oil producer’s shares. It said: “There is no change to our Hold rating. While offering ~10% EPS CAGR to FY28e (on a R24M basis), CBO trades at ~32x FY26e EPS (R24MA basis). This multiple vs. growth equation does not stand out as relative value in the sector.”

    Gold price falls

    ASX 200 gold shares Evolution Mining Ltd (ASX: EVN) and Ramelius Resources Ltd (ASX: RMS) could have a subdued session on Tuesday after the gold price fell overnight. According to CNBC, the gold futures price is down 0.6% to US$4,216.7 an ounce. Traders appear cautious ahead of the US Federal Reserve’s interest rate decision this week.

    The post 5 things to watch on the ASX 200 on Tuesday appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Cobram Estate Olives Limited right now?

    Before you buy Cobram Estate Olives Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cobram Estate Olives Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Up 22% in a year! The red-hot ANZ share price is smashing CBA, Westpac and NAB shares

    Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.

    ASX bank shares make up an important part of many investors’ portfolios. Surprisingly, it is ANZ Group Holdings (ASX: ANZ) that has brought the best returns amongst the big four banks this year. 

    Since the start of the year ANZ shares have risen more than 22%.

    For context, the S&P/ASX 200 BANKS (ASX: XBK) is up 8.7% in the same period. 

    Why the strong rise?

    In January, ANZ shares were trading at roughly $28 and hit a yearly high in November of almost $39. 

    That’s an increase of more than 35%. 

    This was driven by strong business credit, real estate credit growth and investor mortgage growth. 

    However since then, the share price has slid almost 10%. 

    Analysts at Macquarie indicate this could be due to early signs of revenue underperformance. 

    Is there any upside left for ANZ shares?

    After such a strong year, investors may feel they have missed the boat on ANZ shares. 

    Sentiment is seemingly mixed amongst experts. 

    Yesterday, The Motley Fool’s Samantha Menzies reported that Macquarie has neutral rating on ANZ shares with a target price of $35

    This indicates the share price is hovering close to fair value. 

    However, Greg Burke, Equity Strategist at Wilsons Advisor/Canaccord Genuity said in November that ANZ shares are comfortably the ‘best value’ bank on all key valuation metrics, while offering the most attractive yield.

    ANZ has reset its cost base lower and has a strong capital position. ANZ’s 2030 strategy offers a clear pathway to a structurally lower cost-to-income ratio, an improved ROE, and growth in dividends over time. Recent EPS revisions momentum is another relative appeal vs CBA and NAB.

    The sentiment out of the Canaccord Genuity Group last month was that outside of CBA shares, valuations in ASX bank shares are more reasonable. 

    When excluding index heavyweight CBA, valuations are more reasonable – especially relative to a fully priced ASX 200. 

    On average, the Big 4 ex-CBA trade at a modest discount to the market and sit within their historical relative P/E range (vs the ASX 200), albeit towards the upper end. This suggests bank sector valuations are elevated, but not extreme, outside of CBA.

    How have the other big four banks performed?

    After a bull run to start the year, Commonwealth Bank of Australia (ASX: CBA) shares have cooled off considerably. 

    Australia’s largest bank is now relatively flat across 2025, up just 1.2%. 

    National Australia Bank Limited (ASX: NAB) has performed better than CBA, rising approximately 9% since the start of the year. 

    The second best performing big four bank share this year has been Westpac Banking Corporation (ASX: WBC). 

    Westpac shares have risen 18%. 

    The post Up 22% in a year! The red-hot ANZ share price is smashing CBA, Westpac and NAB shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Australia And New Zealand Banking Group right now?

    Before you buy Australia And New Zealand Banking Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Australia And New Zealand Banking Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has positions in National Australia Bank. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This new ASX stock has returned 70% since January

    Man looking at digital holograms of graphs, charts, and data.

    The L1 Long Short Fund Ltd (ASX: LSF) is one of the most successful ASX stocks on the Australian share market.

    Since duplicating its managed fund into a listed investment company (LIC) back in 2018, this LIC’s portfolio has generated an average return of 12.7% per annum. That stretches to 23.1% per annum over the past five years.

    Now, the L1 Long Short Fund is primarily an Australia-focused investment, with ASX stocks making up at least 70% of the fund at any given moment. It is a rather unusual LIC in that it uses a long-short strategy. This involves traditional investing in other shares in hopes of future returns (long investing). But also short-selling companies that it thinks are in for rough times ahead.

    This long-short strategy has clearly been effective at generating returns for its investors on the Australian market. But L1 Capital has just launched a new ASX fund that it hopes can replicate the success of its ASX-focused cousin on the international stage.

    ASX veterans might find a bell ringing when we mention Platinum Asset Management. Platinum used to be one of the ASX’s most sought-after stock pickers. But a recent run of underperformance has left it struggling. As a consequence, Platinum Asset Management’s Platinum Capital Ltd listed investment company was approached by L1 Capital with a takeover offer. The offer was accepted, and, earlier this month, was merged into a new LIC that will take L1’s long-short strategy to global markets.

    That LIC is now known as L1 Global Long Short Fund Ltd (ASX: GLS), and it might be worth a closer look.

    An ASX stock that has banked 70% since January?

    We’ve already touched on the ASX-focused L1 Long Short Fund’s previous success. Even though the L1 Global Long Short Fund has only been on the ASX in its new form for a few days, stock investors have a preview of its potential success.

    In a merger presentation, L1 fund managers Raphael Lamm and Mark Landau seeded an initial version of what has now become the L1 Global Long Short Fund back in January in a trial run of sorts. Between 1 January and 31 October, that trial run returned a whopping 67.5%. 

    Past performance is never a guarantee of future success, of course. But no one can deny that this new ASX stock is off to a flying start.

    Some of the long positions that can currently be found in the L1 Global Long Short Fund’s portfolio include Alcoa, ING and Zillow. Meanwhile, the fund has shorted US electric car maker Lucid Motors.

    L1 will have to keep up its outperformance for new investors to get bang for their buck, though. After an initial grace period, this new ASX stock will charge a management fee of 1.4% per annum. That’s in addition to a performance fee.

    The post This new ASX stock has returned 70% since January appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Platinum Capital Limited right now?

    Before you buy Platinum Capital Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Platinum Capital Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Zillow Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This ASX dividend share is projected to pay an 8% yield by 2027

    Close-up of a business man's hand stacking gold coins into piles on a desktop.

    The ASX dividend share Elders Ltd (ASX: ELD) has seen a sizeable valuation decline since 2022, as the chart below shows. This could be a buying opportunity, in my view.

    The agricultural business has operations across a wide variety of areas, including farming sector retail products, wholesale products, livestock and wool agency services, storage and handling of wool, feed lots for cattle, real estate sales agency and property management services, financial services (including insurance), digital and technical services (including investments in AuctionsPlus and the Clear Grain Exchange online trading platforms), and own-brand agricultural chemicals and animal health products.

    In summary, it’s heavily involved in Australia’s agricultural sector and associated services.

    Following the decline of the Elders share price, it could now offer a very large dividend yield for investors by FY27.

    Passive income projections

    Payouts are decided based on how much profit a company generates as well as how generous the board of directors is feeling.

    According to the projection on CMC Markets, the business is forecast to increase its annual payout per share to 36.5 cents. Following that, the ASX dividend share could grow its dividend to 39.5 cents per share in the 2027 financial year.

    Using the valuation at the time of writing, this translates into a potential grossed-up yield of 8% including franking credits or 5.6% excluding the franking credits.

    Let’s take a look at why now could be a good time to invest in the agricultural business.

    Strong outlook for the ASX dividend share?

    The earnings per share (EPS) forecasts on CMC Markets suggest the business could deliver 58.2 cents of EPS in FY26 and then 63 cents of EPS in FY27. Based on those projections, the Elders share price is valued at just 11x FY27’s estimated earnings.

    When Elders announced its FY25 result, it gave some comments regarding FY26:

    Elders is optimistic about the outlook for FY26, supported by a forecast recovery from dry conditions in South Australia and Victoria, as well as the commencement of benefits following implementation of our new retail system. In addition, we welcome Delta Agribusiness to Elders, expanding our Rural Products business in FY26.

    The outlook and fundamentals for Australian livestock remain sound with prices for sheep and cattle forecast to be supported by strong international demand against a backdrop of tightening supply, especially from regions recovering from drought. The outlook for the regional residential property market remains positive, benefitting from stabilisation of interest rates at lower levels.

    Elders will continue to invest in strategic initiatives, in line with its Eight Point Plan, while maintaining a focus on cost and capital efficiency.

    With that in mind, I think the ASX dividend share could be a good under-the-radar buy for long-term investors.

    The post This ASX dividend share is projected to pay an 8% yield by 2027 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Elders Limited right now?

    Before you buy Elders Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Elders Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Everything Dakota Johnson has worn this year, ranked from least to most daring

    Dakota Johnson at the 2025 Red Sea International Film Festival in Jeddah, Saudi Arabia.
    Dakota Johnson at the Red Sea International Film Festival in Jeddah, Saudi Arabia.

    • Dakota Johnson's style has always been equally chic and bold.
    • That's continued this year, as she's worn daring looks on and off the red carpet.
    • So far, she's sported see-through ensembles, skin-tight sparkles, and more.

    One thing to know about Dakota Johnson is that she's always going to look chic.

    Whether she's walking around New York City, attending the Cannes Film Festival, or posing on a red carpet, her fashion always stands out.

    That's because it's also often pretty daring. In 2025, she's worn everything from see-through ensembles to skin-tight sparkles.

    Here's a look at those outfits and everything else she's worn this year, ranked.

    Dakota Johnson played it safe at a Kering event during the Cannes Film Festival in May.
    Dakota Johnson poses on the red carpet at a Kering Women in Motion Talk hosted in Cannes, France.

    She wore classic black Gucci trousers with sharp pleats, a semi-sheer white blouse, and shiny black loafers from the Italian fashion house.

    Though understated, her outfit was expensive. Her shoes cost $1,050, and her pants cost $2,500.

    She took the same approach to her fashion for the Women in Entertainment Gala in December.
    Dakota Johnson at the 2025 Women in Entertainment Gala in Beverly Hills.
    Dakota Johnson at the 2025 Women in Entertainment Gala in Beverly Hills.

    She wore a chic $2,980 black midi dress from Khaite on the event's red carpet, which highlighted her accessories.

    The latter included $1,140 haircalf heels from the clothing brand, a $2,350 Métier bag, $695 Sophie Buhai earrings, and two onyx rings from the same designer, which cost $2,050 each.

    Inside the gala, she wore a white trench coat with thick buckles on top.

    Her New York City street style in early June was simple.
    Dakota Johnson exits a hotel in New York City.

    She wore a sheer Balenciaga bodysuit on one occasion, but covered it with a leather duster jacket.

    She also sported black Balenciaga jeans, $990 Khaite wedges, The Row's $2,600 Mira clutch, an assortment of Yvonne Leon diamond jewelry, and $590 sunglasses from Khaite's collaboration with Oliver Peoples.

    The actor looked relaxed and casual at one Cannes Film Festival event.
    Dakota Johnson poses in front of photographers at the 2025 Cannes Film Festival in France.

    She wore a $5,200 sleeveless black Gucci dress with a deeply scooped neckline and a crystal hook across the back for the May event.

    The outfit was pretty plain, but elevated thanks to her $1,120 Gucci heels, diamond stud earrings, and a $12,750 Boucheron ring.

    Her shoes stole the show at the Zurich Film Festival in September.
    Dakota Johnson speaks at the Zurich Film Festival in Switzerland.
    Dakota Johnson speaks at the Zurich Film Festival in Switzerland.

    Johnson wore a Ferragamo fit that day to deliver an acting masterclass. It included a $1,750 scarf-embellished top, a miniskirt, and sheer tights.

    Her $2,900 boots, though, were the most daring piece of the ensemble. Designed by Yves Saint Laurent, the leather shoes featured 6.1-inch block heels and platforms across the toes.

    Johnson added a bold touch to a simple after-party outfit in May.
    Dakota Johnson at the "Splitsville" after-party in Cannes, France.

    She arrived at the event in a custom YSL slip dress with an orange floral print. The garment was understated by Johnson's standards, though her jewelry was anything but.

    She wore $115,000 Boucheron earrings made from diamonds and white gold. The statement pieces were shaped like leaves.

    The "Materialists" star wore a glamorous look with a few sharp elements at the 2025 Karlovy Vary Film Festival.
    Dakota Johnson poses with the 2025 KVIFF President's Award in Karlovy Vary, Czech Republic.

    Her dress, a $2,450 piece from Mugler, was strapless with a plunging V-shaped neckline and a long, ankle-length skirt.

    To complement the gown's daring cut, Johnson wore a diamond necklace with an emerald charm from Roberto Coin and a matching emerald ring.

    She completed the look for the July event with $795 Gianvito Rossi pumps.

    In August, she wore a short, sparkling dress with unique shoes.
    Dakota Johnson at a "Splitsville" after party in Los Angeles.
    Dakota Johnson at a "Splitsville" after party in Los Angeles.

    Johnson mostly wore gowns throughout 2025, but she made an exception for the "Splitsville" premiere after-party.

    That night, she wore a green Gucci minidress covered in sequins, paired with the fashion house's pointed black pumps.

    Her accessories were quietly daring at the beginning of June.
    Dakota Johnson walks through New York City while wearing jeans and a yellow jacket.

    While walking around New York City, Johnson was photographed wearing a $98 semi-sheer Commando bodysuit beneath a yellow velvet jacket from Khaite.

    She also wore simple blue jeans, $990 Khaite wedges in black, and dark Gucci sunglasses.

    The daring aspect came in the form of her jewelry, which retails for a combined total of over $140,000. Johnson wore a $10,430 Ophelia Eve emerald necklace and a $130,200 Sophie Bille Brahe piece.

    Johnson strayed from her typical color palette at the Governors Awards.
    Dakota Johnson at the 2025 Governors Awards in Los Angeles.
    Dakota Johnson at the 2025 Governors Awards in Los Angeles.

    Instead, she wore a strapless, seafoam gown from Valentino. The floor-length piece was crafted from textured fabric and featured a gathered waistline.

    Though its silhouette was straightforward, its color was a bold choice for the actor, which paid off.

    She completed the look with jewels from Jessica McCormack.

    You couldn't miss her in August when she stepped onto the "Splitsville" red carpet.
    Dakota Johnson at the "Splitsville" premiere in Los Angeles.
    Dakota Johnson at the "Splitsville" premiere in Los Angeles.

    She wore a strapless, form-fitting gown from Gucci in a striking silver color.

    It contrasted her dark hair and was accessorized to perfection with statement earrings and bangles, all from Roberto Coin.

    In August, Johnson mixed vintage flair and modern design at Vogue World.
    Dakota Johnson at Vogue World in Los Angeles.
    Dakota Johnson at Vogue World in Los Angeles.

    Her Valentino gown had a halter neckline, a black mesh panel beneath its beaded top, and a floor-length skirt.

    The dress was eye-catching and intricate in design.

    She experimented with bright colors and dramatic jewels on the Cannes red carpet.
    Dakota Johnson poses on the red carpet of the 2025 Cannes Film Festival in France.

    For the "Highest 2 Lowest" premiere, Johnson walked the red carpet in a strapless Gucci gown covered with pink fringe. The vibrant color choice was a departure from her usual neutral fashion.

    She also wore massive Boucheron earrings crafted from diamonds, which sparkled in the light.

    Johnson made a million-dollar statement at the end of May.
    Dakota Johnson enters a Roberto Coin event in New York City

    She looked stunning in a strapless maxi gown from Ferragamo, which retails for $1,850, and pumps from the same brand.

    The star of the show, however, was her $1.2 million Roberto Coin necklace. The eye-catching piece was crafted from diamonds, sapphires, and white gold, and it matched her $25,000 blue ring.

    She wore the pieces shortly after being named the Italian jewelry brand's latest ambassador.

    She brought cutouts back at the Red Sea International Film Festival in December.
    Dakota Johnson at the 2025 Red Sea International Film Festival in Jeddah, Saudi Arabia.
    Dakota Johnson at the Red Sea International Film Festival in Jeddah, Saudi Arabia.

    Alessandra Rich designed her cutout dress with a strapless, plunging V-shaped neckline. It also had two waist cutouts and a daring slit in the middle of its skirt.

    Just as bold as the dress was Johnson's selection of jewelry. She wore sparkling rings, earrings, and layered necklaces that covered part of her collarbones and chest.

    The "Materialists" star opted for a skin-hugging gown at the Kering Women in Motion dinner.
    Dakota Johnson poses on the red carpet at the 2025 Kering Women in Motion dinner in Cannes, France.

    Gucci custom-made her sleeveless gown, which was semi-sheer and lined with a strapless leotard.

    She paired the dress with an updo hairstyle and $56,000 Boucheron hoop earrings.

    Her red-carpet gown for the "Saturday Night Live" anniversary special showed even more skin.
    Dakota Johnson poses on the "SNL50: The Anniversary Special" red carpet in New York City.

    Designed by Gucci, the black gown had one long sleeve, an asymmetrical neckline, and fabric hanging down the front and back of her body.

    On the sides, though, it was only held together by the brand's signature horsebit hooks. The latter detail revealed her legs and hips as she walked.

    Johnson took plunging necklines to another level for an appearance on "The Tonight Show."
    Dakota Johnson wears a blazer with a plunging neckline at "The Tonight Show starring Jimmy Fallon."

    Her Ferragamo ensemble included a $1,490 asymmetrical miniskirt and a $2,900 blazer with a curved neckline that dipped beneath her chest.

    She completed the look with sheer black tights and the brand's $980 pumps.

    The black gown she wore to the New York "Materialists" premiere had a daring structure.
    Dakota Johnson attends a "Materialists" screening in New York City.

    From the front, her halter-neck Gucci gown almost looked conservative. Its silk fabric wrapped around her neck and extended into a loose-fitting top.

    From the side, however, you could see the gown's daring backless and sideless cut.

    She seemingly wore her version of a "revenge dress" for a New York City outing in June.
    Dakota Johnson walks around New York City on June 5, 2025.

    After a rumored breakup between Johnson and Chris Martin, the actor was photographed wearing a $775 tulle-wrapped bodysuit and a matching $1,366 sheer skirt from Nensi Dojaka.

    The outfit was dramatic, fashionable, and undoubtedly one of her most daring looks of the year.

    For another appearance at the Red Sea International Film Festival, the actor wore layers of white lace.
    Dakota Johnson at the 2025 Red Sea International Film Festival in Jeddah, Saudi Arabia.
    Dakota Johnson at the Red Sea International Film Festival in Jeddah, Saudi Arabia.

    Chloé designed her billowing gown, which had short tiered sleeves, a deep V-neckline, and a floor-length skirt. The latter and the bodice were both see-through.

    The outfit was daring, as is Johnson's signature, but it was also feminine and timeless.

    One of Johnson's most memorable outfits of the year was worn at the Zurich Film Festival in September.
    Dakota Johnson at the 2025 Zurich Film Festival in Switzerland.
    Dakota Johnson at the 2025 Zurich Film Festival in Switzerland.

    That outfit, of course, was her blue Gucci ball gown. It featured a lace bodice with long sleeves, a high neckline, and a full tulle skirt.

    The dress was as vibrant as it was daring. Johnson wore nothing beneath its see-through top.

    Johnson wore one of the most see-through gowns of her career that same month.
    Dakota Johnson at Kering's Caring for Women dinner in New York City.
    Dakota Johnson at Kering's Caring for Women dinner in New York City.

    She arrived at Kering's Caring for Women dinner wearing a high-neck, long-sleeved dress crafted from sparkling floral lace. The form-fitting Gucci piece sat atop two pieces of black lingerie.

    To complete the look, Johnson added emerald earrings that matched the color of her eyes.

    Read the original article on Business Insider
  • Here’s why Alphabet is the best-performing “Magnificent Seven” stock in 2025 (and why it has room to run in 2026)

    Skate board with the Google logo.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Key Points

    • In the long run, financial results ultimately prevail over market sentiment.
    • Investor perception toward Alphabet has shifted from pessimistic to realistic.
    • Alphabet remains a balanced buy for 2026.

    Let’s turn the calendar back six months to early June. 

    Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) was down over 10% year to date, while the S&P 500 had recovered from the tariff-induced sell-off in April and was roughly flat on the year.

    Fast-forward to today, and Alphabet is up 67% year to date, has more than doubled off of its 52-week low, and surpassed Microsoft to become the third-most valuable company in the world behind Nvidia and Apple. In 2025, Alphabet is by far the best-performing “Magnificent Seven” stock, with Nvidia in a distant second place with a 35.1% year-to-date gain.

    Here’s why Alphabet’s rise wasn’t a fluke, how you can identify Alphabet-like stocks before they pop, and why Alphabet has room to run in 2026. 

    Alphabet was epically mispriced

    Finance classes will teach you theories such as the efficient market hypothesis, which essentially posits that asset prices are accurately determined based on available information. In practical application, the hypothesis attributes outsize gains to taking on outsize risks — effectively discrediting the finding of true value independent of risk in the market.

    Alphabet is a prime example of why the hypothesis is incorrect.

    Earlier this year, Alphabet got so cheap that it traded at a discount to the S&P 500. It was the least expensive Magnificent Seven stock, despite the company generating substantial free cash flow, achieving steady high-margin growth, repurchasing a significant amount of stock, paying dividends, and maintaining a solid balance sheet.

    Simply put, Wall Street failed to price in Alphabet’s growth potential and labeled it as an artificial intelligence (AI) loser. That assumption couldn’t be further from the truth.

    From laggard to leader

    Alphabet has a massively diversified business, spanning Google Search, Google Cloud, YouTube, Android, Google services like Gmail and Google Drive, “other bets” like Waymo and Google Fiber, research and development arm Google DeepMind, and more. But despite all these moving parts, Alphabet still depends on Google Search for over half of its revenue and the majority of its operating income.

    Large language models (LLMs) present the greatest threat to Google Search in its history. And for a while, there were fears that tools like OpenAI, Claude, Copilot, DeepSeek, Grok, and others would slowly erode Alphabet’s once-dominant share of the search market. If queries shifted from web-based text links to conversational, that would disrupt the very fabric of Google Search’s identity.

    Instead of sitting on its hands and letting the LLM wave weather its once-impenetrable moat, Alphabet integrated its model, Gemini, into Google Search, as well as a stand-alone app. Rather than reinvent the wheel, Alphabet essentially upgraded Chrome with AI features, making it more powerful and providing an incentive for users to stay on the platform instead of switching to a different tool entirely.

    The strategy worked. Google Search continues to grow despite upgrades from rival LLMs. Alphabet is generating all-time-high earnings and investing heavily in long-term projects, including the expansion of Google Cloud infrastructure. Alphabet is thriving and is far from being a legacy tech giant, with its best days in the rearview mirror. And yet just six months ago, the market was pricing Alphabet like a washed-up relic.

    Engagement continues to rise on Gemini — with the app surpassing 650 million monthly active users.

    As an added vote of confidence, Berkshire Hathaway announced a stake in Alphabet — marking a stark contrast from quarter after quarter of trimming its Apple position — indicating Warren Buffett and his team perceive Alphabet as a good value.

    Meta Platforms is considering purchasing Alphabet’s Tensor Processing Unit (TPU) chips, which Alphabet developed with Broadcom. Custom-made TPUs are a cost-effective solution for data centers, offering a more affordable alternative in certain applications than graphics processing units, such as those manufactured by Nvidia or Advanced Micro Devices.

    Flipping the script

    Alphabet’s investment thesis has evolved, but the bigger change impacting its stock price is perception. Now, the market views Alphabet as a leader in search through its reimagined Chrome and Gemini. Google’s TPUs are recognized as a leading method for training AI models, opening a new revenue stream for Alphabet by selling TPUs to hyperscalers.

    Alphabet is a textbook example of the upside potential that comes with investing in dirt cheap growth stocks rather than simply betting big on red-hot highfliers. When growth expectations are virtually nonexistent, a company doesn’t have to do much to garner a favorable response from Wall Street.

    If we examine Alphabet’s timeline over the last six or so months, I would say that a significant change occurred in late summer and fall, when Alphabet began to be recognized as a major player in AI rather than a laggard. The recent run-up over the last few weeks is attributed to a positive response to Gemini 3, which was announced in mid-November, and news that Meta was interested in buying TPU chips.

    These announcements are undoubtedly great news for Alphabet investors, but they didn’t emerge from nowhere. Alphabet’s Google Search and Gemini results have been exceptional for several quarters. Alphabet and Broadcom’s seventh-generation TPU is 30 times more powerful than the first cloud TPU from 2018. But still, the partnership has been going on for a while now.

    Alphabet remains a solid buy now

    Alphabet has room to run in 2026 because its valuation is still reasonable at 30 times forward earnings. With multiple levers to pull to grow earnings, Alphabet is a balanced buy now. But it isn’t the dirt cheap value stock it used to be. Now, Alphabet is at a similar valuation to peers like Microsoft and Amazon, and more expensive than Meta Platforms.

    All told, Alphabet is a great example of why there’s a lot of money to be made in the stock market if you can find quality companies that are mispriced because fears are overshadowing fundamentals and growth potential.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Here’s why Alphabet is the best-performing “Magnificent Seven” stock in 2025 (and why it has room to run in 2026) appeared first on The Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Should you invest $1,000 in Alphabet right now?

    Before you buy Alphabet shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Alphabet wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p { margin-bottom: 0 !important; }

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    More reading

    Daniel Foelber has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Advanced Micro Devices, Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, and Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Broadcom and has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended Advanced Micro Devices, Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 strong Australian stocks to buy now with $10,000

    A female CSL investor looking happy holds a big fan of Australian cash notes in her hand representing strong dividends being paid to her

    It’s no surprise to me that the best Australian stocks are able to outperform the ASX share market. Quality is appealing for a reason.

    Investing in great businesses seems like a winning formula, in my opinion. They can continue re-investing the generated profit into great opportunities inside their existing operations which are already performing well.

    Following recent share price declines, I believe both of the Australian stocks below are compelling investments that I’d happily put $10,000 into today.

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

    This investment conglomerate has been demonstrating its quality for a number of decades and it remains a leading example of how to manage a business for the long-term.

    The Australian stock has built an impressive portfolio of assets across a number of industries, including building products, industrial properties, resources, telecommunications, swimming pools, electrification, farming, water entitlements, financial services, credit, healthcare and plenty more.

    The business has designed its portfolio to be defensive and generate strong cash flow in all economic conditions for shareholders. This makes it likely the business can continue growing the cash flow its portfolio generates, which is a key statistic of focus, as it invests in additional opportunities.

    The Soul Patts share price has dropped close to 20% since 10 September 2025, making it a lot cheaper to grab a piece of this excellent business.

    I’m confident the company has a compelling future ahead because of how it can adjust its portfolio when it sees new opportunities arise. Additionally, it can sell assets if it’s no longer optimistic about an investment.

    I think this business is likely to be around in another 20, 30 and 50 years thanks to its investment flexibility, while delivering a solid dividend along the way.

    Pro Medicus Ltd (ASX: PME)

    Pro Medicus describes itself as a leading healthcare informatics company, which provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups around the world.

    The business aims to provide an end-to-end offering in healthcare imaging across radiology information systems (RIS), picture archiving and communication systems (PACS), AI and e-health solutions.

    Pro Medicus’ software is clearly resonating with customers, with the number of large new contracts it’s winning, as well as add-on modules.

    For example, at the start of December, the company announced a seven-year, $25 million contract to add another module for Baycare, which is one of Pro Medicus’ largest existing contracts.

    The Australian stock has rapidly ramped up its revenue – in FY25 alone, revenue climbed 31.9% to $213 million, while net profit after tax (NPAT) surged 39.2% to $115.2 million.

    While revenue growth is strong, the company’s underlying operating profit (EBIT) margin is an extremely high 74% – that’s one of the highest on the ASX. Such a high EBIT margin means most of the revenue translates into profit for the company.

    The Pro Medicus share price has dropped more than 20% since September, making its forward price/earnings (P/E) ratio seem more reasonable. It’s now trading at 99x FY28’s estimated earnings, according to the projection on Commsec at the time of writing.

    The post 2 strong Australian stocks to buy now with $10,000 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Washington H. Soul Pattinson and Company Limited right now?

    Before you buy Washington H. Soul Pattinson and Company Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Washington H. Soul Pattinson and Company Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has positions in Pro Medicus and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.